Skip to Content

1428 10 (Farxiga 10 mg)

Generic Name: dapagliflozin

Pill with imprint 1428 10 is Yellow, Four-sided and has been identified as Farxiga 10 mg. It is supplied by Bristol-Myers Squibb Company.

Farxiga is used in the treatment of diabetes, type 2 and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Farxiga 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 1428 10

Farxiga

Generic Name:
dapagliflozin
Imprint:
1428 10
Strength:
10 mg
Color:
Yellow
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
SGLT-2 inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb Company
National Drug Code (NDC):
00003-1428

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide